Cancer therapy: know your enemy?

por Westhoff, Mike-Andrew, Brühl, Oliver, Debatin, Klaus-Michael
Publicado 2014

How to Respond to Misinformation From the Anti-Vaccine Movement

por Westhoff, Mike-Andrew, Posovszky, Carsten, Debatin, Klaus-Michael
Publicado 2023

A potential role of PI3K inhibition in radiotherapy of glioblastoma multiforme

por Langhans, Julia, Schneele, Lukas, Debatin, Klaus-Michael, Westhoff, Mike-Andrew
Publicado 2015

Targeting super-enhancers reprograms glioblastoma central carbon metabolism

por Nguyen, Trang T.T., Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2021

Killing Me Softly—Future Challenges in Apoptosis Research

por Westhoff, Mike-Andrew, Brühl, Oliver, Nonnenmacher, Lisa, Karpel-Massler, Georg, Debatin, Klaus-Michael
Publicado 2014

Precision medicine in pediatric oncology

por Burdach, Stefan E. G., Westhoff, Mike-Andrew, Steinhauser, Maximilian Felix, Debatin, Klaus-Michael
Publicado 2018

Correction to: Precision medicine in pediatric oncology

por Burdach, Stefan E. G., Westhoff, Mike-Andrew, Steinhauser, Maximilian Felix, Debatin, Klaus-Michael
Publicado 2022

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma

por Nguyen, Trang T. T., Shang, Enyuan, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2022

Targeting cellular respiration as a therapeutic strategy in glioblastoma

por Shang, Enyuan, Nguyen, Trang Thi Thu, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2023

Cerebral Microstructural Alterations after Radiation Therapy in High-Grade Glioma: A Diffusion Tensor Imaging-Based Study

por Kassubek, Rebecca, Gorges, Martin, Westhoff, Mike-Andrew, Ludolph, Albert C., Kassubek, Jan, Müller, Hans-Peter
Publicado 2017

Cell death-based treatment of childhood cancer

por Westhoff, Mike-Andrew, Marschall, Nicolas, Grunert, Michael, Karpel-Massler, Georg, Burdach, Stefan, Debatin, Klaus-Michael
Publicado 2018

Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma

por Shang, Enyuan, Nguyen, Trang T. T., Shu, Chang, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2020

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells

por Burster, Timo, Traut, Rebecca, Yermekkyzy, Zhanerke, Mayer, Katja, Westhoff, Mike-Andrew, Bischof, Joachim, Knippschild, Uwe
Publicado 2021

Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina”

por Westhoff, Mike-Andrew, Baisch, Tim, Herbener, Verena J., Karpel-Massler, Georg, Debatin, Klaus-Michael, Strobel, Hannah
Publicado 2020

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma

por Westhoff, Mike-Andrew, Faham, Najmeh, Marx, Daniela, Nonnenmacher, Lisa, Jennewein, Claudia, Enzenmüller, Stefanie, Gonzalez, Patrick, Fulda, Simone, Debatin, Klaus-Michael
Publicado 2013

Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma

por Ishida, Chiaki Tsuge, Shu, Chang, Halatsch, Marc-Eric, Westhoff, Mike-Andrew, Altieri, Dario C., Karpel-Massler, Georg, Siegelin, Markus David
Publicado 2017

Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems

por Shang, Enyuan, Zhang, Yiru, Shu, Chang, Ishida, Chiaki Tsuge, Bianchetti, Elena, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2018

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy

por Strobel, Hannah, Baisch, Tim, Fitzel, Rahel, Schilberg, Katharina, Siegelin, Markus D., Karpel-Massler, Georg, Debatin, Klaus-Michael, Westhoff, Mike-Andrew
Publicado 2019

Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems

por Nguyen, Trang T. T., Zhang, Yiru, Shang, Enyuan, Shu, Chang, Quinzii, Catarina M., Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2020

TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo

por Karpel-Massler, Georg, Bâ, Maïmouna, Shu, Chang, Halatsch, Marc-Eric, Westhoff, Mike-Andrew, Bruce, Jeffrey N., Canoll, Peter, Siegelin, Markus D.
Publicado 2015